| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Aims and Scope/Editorial Board/Publishing Details
|
|
|
2010
|
38 |
1 |
p. IFC-
1 p.
|
artikel
|
| 2 |
Alternative strategies in assuring blood safety: An Overview
|
Epstein, Jay S.
|
|
2010
|
38 |
1 |
p. 31-35
5 p.
|
artikel
|
| 3 |
Blood donation in Chile: Replacement and volunteer donors
|
Herrera, Claudia
|
|
2010
|
38 |
1 |
p. 36-38
3 p.
|
artikel
|
| 4 |
Characterization of variant diphtheria toxin–interleukin-3 fusion protein, DTIL3K116W, for phase I clinical trials
|
Su, Yunpeng
|
|
2010
|
38 |
1 |
p. 144-149
6 p.
|
artikel
|
| 5 |
Cloning and expression of a region of vesicle associated membrane protein2 (VAMP2) gene and its use as a recombinant peptide substrate for assaying clostridial neurotoxins in contaminated biologicals
|
Moghaddam, Mehrdad Moosazadeh
|
|
2010
|
38 |
1 |
p. 113-119
7 p.
|
artikel
|
| 6 |
Design and development of a method for the reduction of infectious pathogen load and inactivation of white blood cells in whole blood products
|
Goodrich, Raymond P.
|
|
2010
|
38 |
1 |
p. 20-30
11 p.
|
artikel
|
| 7 |
Donor issues in Indonesia: A developing country in South East Asia
|
Soedarmono, Yuyun S.M.
|
|
2010
|
38 |
1 |
p. 43-46
4 p.
|
artikel
|
| 8 |
Evaluation of cell substrates for the production of biologicals: Revision of WHO recommendations
|
Knezevic, I.
|
|
2010
|
38 |
1 |
p. 162-169
8 p.
|
artikel
|
| 9 |
Filler Ad: Mode of Action of Adjuvants
|
|
|
2010
|
38 |
1 |
p. ii-
1 p.
|
artikel
|
| 10 |
Foreword
|
Allain, Jean-Pierre
|
|
2010
|
38 |
1 |
p. 1-
1 p.
|
artikel
|
| 11 |
Fostering repeat donations in Ghana
|
Owusu-Ofori, S.
|
|
2010
|
38 |
1 |
p. 47-52
6 p.
|
artikel
|
| 12 |
Health economics of blood transfusion safety – focus on sub-Saharan Africa
|
van Hulst, Marinus
|
|
2010
|
38 |
1 |
p. 53-58
6 p.
|
artikel
|
| 13 |
Hemovigilance in developing countries
|
Ayob, Yasmin
|
|
2010
|
38 |
1 |
p. 91-96
6 p.
|
artikel
|
| 14 |
How safe is blood, really?
|
Klein, Harvey G.
|
|
2010
|
38 |
1 |
p. 100-104
5 p.
|
artikel
|
| 15 |
Improving availability and affordability of plasma-derived medicines
|
Cheraghali, Abdol Majid
|
|
2010
|
38 |
1 |
p. 81-86
6 p.
|
artikel
|
| 16 |
Influence of ethanol on the release of growth factors in human blood-derived platelet gels
|
Kuo, Ya Po
|
|
2010
|
38 |
1 |
p. 120-127
8 p.
|
artikel
|
| 17 |
l-Proline reduces IgG dimer content and enhances the stability of intravenous immunoglobulin (IVIG) solutions
|
Bolli, Reinhard
|
|
2010
|
38 |
1 |
p. 150-157
8 p.
|
artikel
|
| 18 |
Management of blood system in disasters
|
Kuruppu, Kumudu K.S.
|
|
2010
|
38 |
1 |
p. 87-90
4 p.
|
artikel
|
| 19 |
Material & equipment, procurement & maintenance: Impact on blood safety
|
Emmanuel, Jean C.
|
|
2010
|
38 |
1 |
p. 78-80
3 p.
|
artikel
|
| 20 |
Meeting of the Strategic Advisory Group of Experts on immunization, October 2009 – Conclusions and recommendations
|
WHO,
|
|
2010
|
38 |
1 |
p. 170-177
8 p.
|
artikel
|
| 21 |
Microarray blood testing: Pros & cons
|
Petrik, Juraj
|
|
2010
|
38 |
1 |
p. 2-8
7 p.
|
artikel
|
| 22 |
Nanotechnologies for pathogen detection: Future alternatives?
|
Fournier-Wirth, Chantal
|
|
2010
|
38 |
1 |
p. 9-13
5 p.
|
artikel
|
| 23 |
Nomenclature and guideline to express the amount of a membrane protein synthesized in animal cells in view of bioprocess optimization and production monitoring
|
Augusto, Elisabeth F.P.
|
|
2010
|
38 |
1 |
p. 105-112
8 p.
|
artikel
|
| 24 |
Nucleic acid testing (NAT) in high prevalence–low resource settings
|
El Ekiaby, Magdy
|
|
2010
|
38 |
1 |
p. 59-64
6 p.
|
artikel
|
| 25 |
Optimal use of blood in trauma patients
|
Holcomb, John B.
|
|
2010
|
38 |
1 |
p. 72-77
6 p.
|
artikel
|
| 26 |
Recruitment of blood donors in Burkina Faso: how to avoid donations from family members?
|
Dahourou, Honorine
|
|
2010
|
38 |
1 |
p. 39-42
4 p.
|
artikel
|
| 27 |
Removal of TSE agents by depth or membrane filtration from plasma products
|
Roberts, Peter L.
|
|
2010
|
38 |
1 |
p. 158-161
4 p.
|
artikel
|
| 28 |
Self-sufficiency, free trade and safety
|
Rautonen, Jukka
|
|
2010
|
38 |
1 |
p. 97-99
3 p.
|
artikel
|
| 29 |
Should we neglect or nurture replacement blood donors in sub-Saharan Africa?
|
Bates, Imelda
|
|
2010
|
38 |
1 |
p. 65-67
3 p.
|
artikel
|
| 30 |
Testing genotoxicity and cytotoxicity strategies for the evaluation of commercial radiosterilized fetal calf sera
|
Pilili, Juan Pablo
|
|
2010
|
38 |
1 |
p. 135-143
9 p.
|
artikel
|
| 31 |
The effect of salt concentration on the prekallikrein activator assay
|
Georgakopoulos, Thanae
|
|
2010
|
38 |
1 |
p. 178-179
2 p.
|
artikel
|
| 32 |
The influence of the inactivating agent on the antigen content of inactivated Newcastle disease vaccines assessed by the in vitro potency test
|
Jagt, H.J.M.
|
|
2010
|
38 |
1 |
p. 128-134
7 p.
|
artikel
|
| 33 |
Treatment of whole blood (WB) and red blood cells (RBC) with S-303 inactivates pathogens and retains in vitro quality of stored RBC
|
Mufti, N.A.
|
|
2010
|
38 |
1 |
p. 14-19
6 p.
|
artikel
|
| 34 |
Whole blood and component use in resource poor settings
|
Marwaha, Neelam
|
|
2010
|
38 |
1 |
p. 68-71
4 p.
|
artikel
|
Tijdschrift beschrijving